The Biotech Startups Podcast
🧬 Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)
April 14, 2025
"I was born and raised in a developing country. I was born and raised in Pakistan. And it's very interesting when you're born in a developing country. That's your world. Right? That's all you know." In this episode of The Biotech Startups Podcast, we delve into Rabia Khan's remarkable journey from her childhood in Pakistan to founding Serna Bio, an AI-enabled drug discovery company. Rabia shares how her early experiences in a developing country, her aunt's battle with schizophrenia, and the sequencing of the human genome in 2000 sparked her passion for genetics and healthcare. She recounts how her career options were either medicine or engineering, setting her on a path that would eventually lead to pioneering work at the intersection of AI and biotechnology. Rabia describes her transition to McGill University in Montreal, facing the shock of -40°C weather with only a leather jacket while navigating life as an international student with no support system. Despite these challenges, she pursued dual interests in biology and economics, finding her first research opportunity in a schizophrenia lab where she started by pipetting water and washing dishes.
🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.

As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.

"I was born and raised in a developing country. I was born and raised in Pakistan. And it's very interesting when you're born in a developing country. That's your world. Right? That's all you know."

In this episode of The Biotech Startups Podcast, we delve into Rabia Khan's remarkable journey from her childhood in Pakistan to founding Serna Bio, an AI-enabled drug discovery company. Rabia shares how her early experiences in a developing country, her aunt's battle with schizophrenia, and the sequencing of the human genome in 2000 sparked her passion for genetics and healthcare. She recounts how her career options were either medicine or engineering, setting her on a path that would eventually lead to pioneering work at the intersection of AI and biotechnology.

Rabia describes her transition to McGill University in Montreal, facing the shock of -40°C weather with only a leather jacket while navigating life as an international student with no support system. Despite these challenges, she pursued dual interests in biology and economics, finding her first research opportunity in a schizophrenia lab where she started by pipetting water and washing dishes. 

Key topics covered:


If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

Subscribe to the Podcast:
Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4
Youtube: https://www.youtube.com/@thebiotechstartupspodcast 
Website: https://www.thebiotechstartupspodcast.com/ 

Find our guest, Rabia Khan, at these links: 
LinkedIn: https://www.linkedin.com/in/rabiatkhan/ 
Website: https://www.serna.bio/ 

Find our host, Jon Chee, at these links: 
LinkedIn: https://www.linkedin.com/in/jonchee

Learn more about Excedr:
LinkedIn: https://www.linkedin.com/company/excedr/ 
Website: https://www.excedr.com

Intro & Outro Songs Created by OkKyojin, Owned by Excedr:
Website: https://flow.page/kyojin 

Resources & Articles:
The Human Genome Project https://www.genome.gov/human-genome-project 
Schizophrenia https://en.wikipedia.org/wiki/Schizophrenia 
Opportunity Cost https://www.investopedia.com/terms/o/opportunitycost.asp 
Marginal Utility https://www.investopedia.com/terms/m/marginalutility.asp 
The Prisoner's Dilemma https://en.wikipedia.org/wiki/Prisoner%27s_dilemma 
Ray Dalio's Decision Making Frameworks https://www.principles.com/principles/7df5502f-46e5-47d5-8fd7-8fc70843b726/ 
Nassim Taleb's Antifragility https://en.wikipedia.org/wiki/Antifragile_(book) 
Black Swan by Nassim Taleb https://en.wikipedia.org/wiki/The_Black_Swan:_The_Impact_of_the_Highly_Improbable 
McGill University's Human Genetics Program https://www.mcgill.ca/humangenetics/our-programs/program-information 
Hydatidiform Moles Research https://www.ncbi.nlm.nih.gov/books/NBK459155/ 

Companies, Universities, & People mentioned:
Benevolent AI: https://www.benevolent.com/ 
Meta: https://techcrunch.com/2017/01/23/chan-zuckerberg-initiative-meta/  
Bayer: https://www.bayer.com/ 
BMS (Bristol Myers Squibb): https://www.bms.com/ 
Roche: https://www.roche.com/ 
Alexion: https://www.alexion.com/ 

Gustavo Turecki https://douglas.research.mcgill.ca/gustavo-turecki/ 
Rima Slim https://scholar.google.ca/citations?user=UwK8NS8AAAAJ&hl=en 
Danielle Malo https://www.linkedin.com/in/danielle-malo-a204a174/ 
Ray Dalio https://www.linkedin.com/in/raydalio/ 
Nassim Taleb https://en.wikipedia.org/wiki/Nassim_Nicholas_Taleb 

Timestamps:
00:00 Intro
03:18 Upbringing in Pakistan and Early Influences
07:27 Formative Experiences: Human Genome Sequencing and Aunt's Schizophrenia
13:49 Educational Experience: British System and Academic Rigor
17:21 Economics and Biology: Dual Interests and Decision Making Frameworks
23:31 Decision Making: Opportunity Cost and Probabilistic Thinking
28:51 International Education: Choosing McGill University
34:09 First Lab Experience: Working in a Schizophrenia Research Lab
40:43 Undergraduate Research: Discovering the Gene for Hydatidiform Moles
45:43 Father's Influence on PhD Decision
48:31 Outro

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.